Initial evaluation of a 290-microm diameter subcutaneous glucose sensor: glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans
- PMID: 9877461
- DOI: 10.1016/s1056-8727(98)00011-7
Initial evaluation of a 290-microm diameter subcutaneous glucose sensor: glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans
Abstract
Results of the initial clinical evaluation in 20 human subjects of a subcutaneously implanted microsensor-based amperometrically glycemia-monitoring system, carried out between April 1994 and June 1995, are reported. The system was based on the electrical connection ("wiring") of the reaction centers of glucose oxidase to a gold electrode and on elimination of the chemicals that interfere with glucose monitoring through their horseradish peroxidase-catalyzed oxidation by internally generated hydrogen peroxide. The sensor was finer than a 29-gauge needle and had no leachable components. Because of its high selectivity for glucose, the sensor output was virtually nil at zero glucose level. This enables prompt "one-point" in vivo calibration of the sensor with a single blood glucose sample. Microsensors were subcutaneously implanted in ten nondiabetic and ten insulin-dependent diabetes mellitus (IDDM) volunteers. All subjects underwent standard meal tests and intravenous glucose-tolerance tests (IVGTT) in addition to hourly plasma glucose measurements. The sensor signals were continuously recorded, and the glucose concentration estimates were derived by calibrating the sensor using a single blood sample (one-point calibration). Regression analysis revealed that the sensor-estimated glucose concentrations were linearly related to the plasma glucose concentrations (r2 = 0.75) over a wide glucose concentration range (2-28 mmol/L) (sensor estimate = plasma 0.96 + 0.26 mmol/L). The difference between the estimated and actual glucose concentration was -0.13+/-0.23 mmol/L [mean +/-95% confidence interval (CI), n = 546], and 95% of the estimates fell in clinically acceptable zones of the Clarke error grid. The sensing delay time was 10.4+/-2.3 min as measured by the IVGTT. The subjects reported no discomfort associated with wearing the sensors.
Similar articles
-
Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans.Diabetes Technol Ther. 2004 Jun;6(3):378-86. doi: 10.1089/152091504774198089. Diabetes Technol Ther. 2004. PMID: 15198842
-
A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration.Diabetes Care. 2000 Feb;23(2):208-14. doi: 10.2337/diacare.23.2.208. Diabetes Care. 2000. PMID: 10868833
-
Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method.Biosens Bioelectron. 2002 Aug;17(8):647-54. doi: 10.1016/s0956-5663(01)00304-9. Biosens Bioelectron. 2002. PMID: 12052350
-
Progress toward the development of an implantable sensor for glucose.Clin Chem. 1992 Sep;38(9):1613-7. Clin Chem. 1992. PMID: 1525989 Review.
-
Implanted electrochemical glucose sensors for the management of diabetes.Annu Rev Biomed Eng. 1999;1:153-75. doi: 10.1146/annurev.bioeng.1.1.153. Annu Rev Biomed Eng. 1999. PMID: 11701486 Review.
Cited by
-
Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis.J Diabetes Sci Technol. 2007 Sep;1(5):746-52. doi: 10.1177/193229680700100520. J Diabetes Sci Technol. 2007. PMID: 19885143 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous